| Ansøgningsnr. og dato | 13861470.6 (espacenet) (Federated) (European Patent Register), 20131206 | | Patent/reg.nr. og dato | DK/EP 2928495, 20190327 | | Tilgængelighedsdato | 20151014 | | Prioritetsnr. og dato | US 201261734524 P, 20121207, US 201361769247 P, 20130226, US 201361808372 P, 20130404 | | EP publ. nr. og dato |
EP 2928495 20151014 | | Løbedag | | | Ansøger/indehaver | Sanofi-Aventis U.S. LLC, 55 Corporate Drive
Bridgewater, NJ 08807, US,
The Regents of the University of California, 1111 Franklin Street, 12th Floor
Oakland, CA 94607, US | | Ansøgers ref. nr. | Morrison & Foerster LLP 18395-20006.XX[FR2012/054] | | Opfinder | TOMKINSON, Blake, c/o Sanofi-Aventis
55 Corporate Drive
Bridgewater
New Jersey 08807, US,
HANN, Byron, C., c/o University of California San Francisco
HDF Comprehensive Cancer Ctr Box 0875
2340 Sutter Street
San Francisco
California 94143, US,
MARTIN, III, Thomas, G., c/o University of California San Francisco
Hematology/Oncology Box 0324
400 Parnassus Ave
UC Clinics
San Francisco
California 94143, US,
AFTAB, Blake, T., c/o University of California San Francisco
HDF Comprehensive Cancer Ctr Box 0128
1450 3rd Street
San Francisco
California 94158, US | | Fuldmægtig | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Interessent på tilknyttet sag | | | IPC-Klasse | A61K 31/37 (2006.01) , A61K 31/4439 (2006.01) , A61K 31/454 (2006.01) , A61K 31/573 (2006.01) , A61K 31/616 (2006.01) , A61K 31/727 (2006.01) , A61K 39/00 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Titel/benævnelse | SAMMENSÆTNINGER, DER OMFATTER ANTI-CD38-ANTISTOFFER OG LENALIDOMID | | Internationalt ansøgningsnr. | US2013073540 | | Internationalt publ. nr. | WO2014089416 | | Relateret sag (certifikat) | CA 2020 00056 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
